After 20 Years in Clinical Research, One Thing Has Become Clear About Investing in Quality
There are moments in your career that make you stop and reflect. As I'm about to begin my 20th year working in clinical research, I've found myself thinking about the incredible range of organizations I've had the privilege to meet and work alongside. From NHS research teams and independent research sites to global site networks, sponsors, CROs and academic institutions, every organization has approached quality in its own way.
Yet despite their differences, the organizations that consistently stand out often share one important characteristic - they invest in organizational quality before they're asked to. Not because an inspection is looming, not because a sponsor has requested it, but because they recognize that quality is fundamental to building a sustainable, high-performing research organization.
The conversation around quality is changing
When I first entered the industry, quality was often viewed through the lens of compliance. Today, the conversation is much broader.
Clinical trials are becoming increasingly complex. Study timelines are accelerating. Expectations around workforce capability, operational resilience and participant experience continue to grow. Sponsors and CROs aren't simply looking for clinical trial sites that can deliver a study; they're looking for organizations that can consistently deliver research excellence. That shift is significant.
Increasingly, it's not enough to say your research site organization operates to a high standard; organizations are being asked to demonstrate it.
Quality goes far beyond audits
Throughout my career, I've worked with many organizations that have strong internal quality processes. Internal audits, SOP reviews and continuous improvement activities are all essential as they help organizations understand themselves, identify opportunities for improvement and strengthen day-to-day operations. However, internal assurance and independent assurance are two very different things; one provides confidence from within and the other provides confidence to the wider industry.
As research becomes more collaborative and globally connected, that independent demonstration of organizational capability is becoming increasingly valuable.
Looking beyond individual studies
One observation I've made over the years is that the strongest organizations don't focus solely on delivering today's study; they're thinking about the organization they'll become over the next five or ten years.
They ask questions such as:
- Are our leadership structures supporting long-term growth?
- Are we investing enough in our workforce?
- Are our processes consistent and scalable?
- Could someone new join tomorrow and experience the same high standards across every study?
- Are we building resilience as well as compliance?
Those are strategic questions, not just operational ones, and they're becoming increasingly important as the research landscape continues to evolve.
Why I believe independent clinical research site certification with GCSA matters
Having worked across different parts of the industry, one aspect of GCSA that particularly resonates with me is its focus on the organization as a whole. Research excellence doesn't happen because of one outstanding individual or one successful inspection. It comes from strong leadership, capable people, effective governance, robust systems and a culture of continuous improvement.
GCSA recognizes that reality.
Rather than focusing solely on study compliance, GCSA provides an independent framework for assessing the organizational capability that underpins consistently high-quality clinical research. It encourages organizations to step back, benchmark themselves against recognized best practice and identify opportunities to become stronger, more resilient and better prepared for future growth.
An investment in the future
Every organization has to make choices about where it invests.
- Technology
- Facilities
- People
- Training
- Business development
In my view, investment in organizational quality deserves to sit alongside all of these.
Not because certification is the end goal, but because the process of understanding, strengthening and independently validating how an organization operates can create lasting value. It helps build confidence internally, demonstrates credibility externally and supports long-term sustainability.
Looking ahead
As I begin my 20th year in this industry, I remain incredibly optimistic about where clinical research is heading. I've seen first-hand the dedication, innovation and commitment that exists across research organizations around the world.
I also believe we're entering a new chapter; one where organizational capability, workforce excellence and independently demonstrated quality will play an increasingly important role in building trusted research partnerships.
For me, that's what makes initiatives like GCSA clinical research site certification so important.
Not because they replace the excellent work organizations are already doing, but because they provide a meaningful way to recognize it, strengthen it and demonstrate it to the wider research community.
Ultimately, investing in organizational quality isn't simply about achieving certification.
It's about building research organizations that are equipped to deliver better studies, stronger partnerships and better outcomes for the paarticipants who depend on clinical research.
To find out more about how GCSA can support your site or site network, please do contact me directly to set up an introductory call:
Vicky Toms | Executive Director of Business Growth and Oversight
Email: vtoms@iaocr.com